ArticleJournal of clinical medicine2023

Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry.

Andreas A Argyriou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.